BioCorRx Inc. financial data

Symbol
BICX on OTC
Location
Anaheim, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.2% % 76%
Quick Ratio 0.82% %
Debt-to-equity -143% % -36%
Return On Equity 6909% % 8365%
Return On Assets -98% % 91%
Operating Margin -572% % 97%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23,685,343 shares 117%
Common Stock, Shares, Outstanding 11,211,595 shares 0%
Entity Public Float $2,716,686 USD -70%
Common Stock, Value, Issued $20,188 USD 80%
Weighted Average Number of Shares Outstanding, Basic 17,011,680 shares 80%
Weighted Average Number of Shares Outstanding, Diluted 18,162,783 shares 67%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $948,361 USD 3465%
Cost of Revenue $0 USD -100%
Research and Development Expense $1,735,982 USD 30%
Operating Income (Loss) $5,422,193 USD -12%
Nonoperating Income (Expense) $1,157,018 USD 675%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,265,175 USD 14%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $5,263,291 USD -7.2%
Earnings Per Share, Diluted -0.11 USD/shares 21%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $194,442 USD
Inventory, Net $155,367 USD
Assets, Current $1,462,176 USD 314%
Property, Plant and Equipment, Net $7,685 USD -76%
Operating Lease, Right-of-Use Asset $169,443 USD -19%
Goodwill $2,840,400 USD
Assets $7,533,473 USD 1071%
Accounts Payable, Current $6,725,664 USD 117%
Liabilities, Current $15,038,127 USD 83%
Operating Lease, Liability, Noncurrent $127,757 USD -25%
Liabilities $20,297,768 USD 60%
Retained Earnings (Accumulated Deficit) $87,201,843 USD -6.3%
Stockholders' Equity Attributable to Parent $13,484,639 USD -14%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $12,764,295 USD -6.3%
Liabilities and Equity $7,533,473 USD 1071%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $689,623 USD -103%
Net Cash Provided by (Used in) Financing Activities $625,732 USD 67%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 20,188,029 shares 80%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $287,688 USD 220%
Interest Paid, Excluding Capitalized Interest, Operating Activities $722 USD -92%
Deferred Tax Assets, Valuation Allowance $12,347,394 USD 10%
Deferred Tax Assets, Gross $12,386,743 USD 8.4%
Operating Lease, Liability $208,709 USD 197%
Depreciation $22,076 USD -14%
Lessee, Operating Lease, Liability, to be Paid $209,085 USD -16%
Property, Plant and Equipment, Gross $194,551 USD 0%
Operating Lease, Liability, Current $41,686 USD 6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $27,272 USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year One $13,636 USD -65%
Deferred Income Tax Expense (Benefit) $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $54,544 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $8,249,727 USD 3.5%
Preferred Stock, Shares Authorized 600,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $54,544 USD 0%
Operating Lease, Payments $4,545 USD
Additional Paid in Capital $73,575,400 USD 5%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $203,282 USD 64%
Interest Expense $281,895 USD -63%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares